Additionally, the treatment during four weeks with N-acetyl cysteine, which activates the Nrf2 pathway, showed better scores on the Unified Parkinson Disease Rating Scale and increased peripheral markers of antioxidant activity [221]. This evidence concerns the gene NFE2L2 and Parkinson disease.